Just in! The FDA approved Tolvaptan for the treatment of ADPKD today. I'm blessed to say I have been in the clinical trial group for this drug for over 2 years and I do believe it has helped me. There is still a lot to figure out regarding pricing, dispensing, educating medical professionals, and the care plan for anyone on the drug. I'll take the win for now!
More here: businesswire.com/news/home/...